Francesco Bernardi Selected Research

Factor VII (Proconvertin)

1/2021	Biochemical, molecular and clinical aspects of coagulation factor VII and its role in hemostasis and thrombosis.
3/2012	Promoter methylation in coagulation F7 gene influences plasma FVII concentrations and relates to coronary artery disease.
8/2010	Chronic sleep deprivation markedly reduces coagulation factor VII expression.
2/2009	Temporal and genotype-driven variation of factor VII levels in patients with acute myocardial infarction.
12/2006	Tissue factor and coagulation factor VII levels during acute myocardial infarction: association with genotype and adverse events.
3/2005	Clinical phenotypes and factor VII genotype in congenital factor VII deficiency.
9/2004	Influence of polymorphisms in the factor VII gene promoter on activated factor VII levels and on the risk of myocardial infarction in advanced coronary atherosclerosis.
2/2002	Residual factor VII activity and different hemorrhagic phenotypes in CRM(+) factor VII deficiencies (Gly331Ser and Gly283Ser).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Francesco Bernardi Research Topics

Disease

9	Hemophilia B (Haemophilia B) 01/2022 - 06/2012
9	Hemorrhage 01/2021 - 12/2003
9	Multiple Sclerosis 01/2021 - 01/2017
8	Coronary Artery Disease (Coronary Atherosclerosis) 01/2021 - 09/2004
6	Hemophilia A (Haemophilia) 01/2022 - 09/2012
6	Venous Thromboembolism 10/2005 - 05/2003
5	Inflammation (Inflammations) 08/2021 - 03/2007
5	Thrombophilia 10/2005 - 09/2002
4	Factor VII Deficiency (Hypoproconvertinemia) 03/2018 - 02/2002
4	Myocardial Infarction 02/2009 - 09/2004
3	Thrombosis (Thrombus) 01/2021 - 10/2005
3	Activated Protein C Resistance (APC Resistance) 10/2005 - 06/2003
2	Type 2 von Willebrand Disease 01/2020 - 12/2010
2	Atrophy 01/2020 - 01/2019
2	Fatigue 07/2019 - 01/2017
2	Inborn Genetic Diseases (Disease, Hereditary) 01/2017 - 07/2012
2	Venous Thrombosis (Deep-Vein Thrombosis) 03/2005 - 10/2003
1	Ornithine Carbamoyltransferase Deficiency Disease 12/2021
1	Hepatocellular Carcinoma (Hepatoma) 12/2021
1	Alzheimer Disease (Alzheimer's Disease) 08/2021
1	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 08/2021
1	Myocardial Ischemia (Ischemic Heart Diseases) 01/2021
1	Thrombocytopenia (Thrombopenia) 01/2020
1	Fabry Disease (Fabry's Disease) 01/2020
1	Disease Susceptibility (Diathesis) 02/2019
1	Neuroinflammatory Diseases 01/2019
1	Atherosclerotic Plaque (Atheroma) 09/2013
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 08/2013
1	Leukemia 12/2012
1	Neoplasms (Cancer) 12/2012
1	Cystic Fibrosis (Mucoviscidosis) 06/2012
1	Spinal Muscular Atrophy (Progressive Muscular Atrophy) 06/2012

Drug/Important Bio-Agent (IBA)

8	Factor VII (Proconvertin)IBA 01/2021 - 02/2002
7	Factor IX (Coagulation Factor IX)FDA LinkGeneric 01/2022 - 09/2012
6	Proteins (Proteins, Gene)FDA Link 08/2021 - 09/2002
5	Thrombin FDA Link 02/2019 - 12/2003
5	Blood Coagulation Factors (Coagulation Factor)IBA 01/2019 - 09/2002
5	Factor V (Coagulation Factor V)IBA 07/2013 - 10/2003
4	Factor VIII (Coagulation Factor VIII)IBA 01/2022 - 03/2005
4	Nonsense Codon (Nonsense Mutation)IBA 01/2020 - 09/2012
3	CoagulantsIBA 01/2021 - 12/2010
3	Factor VIIa (Activated Factor VII)IBA 01/2020 - 09/2004
3	ChemokinesIBA 01/2020 - 01/2017
3	Blood Proteins (Serum Proteins)IBA 01/2020 - 01/2017
3	LigandsIBA 01/2020 - 10/2018
3	Messenger RNA (mRNA)IBA 01/2020 - 03/2008
3	Protein CIBA 01/2020 - 03/2005
3	Biomarkers (Surrogate Marker)IBA 07/2019 - 01/2017
3	factor V LeidenIBA 10/2005 - 06/2003
2	NucleotidesIBA 12/2021 - 01/2019
2	Biological ProductsIBA 01/2021 - 03/2005
2	CC ChemokinesIBA 01/2020 - 07/2019
2	von Willebrand FactorIBA 01/2020 - 12/2010
2	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 07/2019 - 01/2019
2	LipidsIBA 07/2019 - 12/2010
2	Thromboplastin (Tissue Factor)IBA 02/2019 - 12/2006
2	Apolipoprotein C-IIIIBA 02/2019 - 11/2013
2	Pharmaceutical PreparationsIBA 01/2017 - 12/2012
2	RNA Splice SitesIBA 09/2015 - 03/2008
2	AnticoagulantsIBA 04/2010 - 07/2003
1	Asialoglycoprotein ReceptorIBA 01/2022
1	RNA (Ribonucleic Acid)IBA 12/2021
1	Amyloid (Amyloid Fibrils)IBA 08/2021
1	SelectinsIBA 01/2021
1	Human Serum Albumin FDA LinkGeneric 01/2021
1	Prothrombin (Factor II)IBA 01/2021
1	N 30IBA 01/2021
1	neonatal Fc receptorIBA 01/2021
1	Pyruvic Acid (Pyruvate)IBA 10/2020
1	Lactic Acid (Lactate)FDA LinkGeneric 10/2020
1	CollagenIBA 01/2020
1	Adenosine Diphosphate (ADP)IBA 01/2020
1	GalactosidasesIBA 01/2020
1	AntigensIBA 01/2020
1	AntithrombinsIBA 01/2020
1	RistocetinIBA 01/2020
1	Chemokine CCL5IBA 07/2019
1	HDL CholesterolIBA 07/2019
1	CholesterolIBA 07/2019
1	NexusIBA 07/2019
1	estropipate (Ogen)FDA LinkGeneric 01/2019
1	FibrinIBA 01/2019
1	Neural Cell Adhesion Molecules (Neural Cell Adhesion Molecule)IBA 01/2019
1	EnzymesIBA 03/2018
1	Factor XII (Hageman Factor)IBA 01/2018
1	ElementsIBA 01/2018
1	Peptides (Polypeptides)IBA 01/2018
1	Nerve Growth Factors (Neurotrophins)IBA 01/2017
1	antibiotic G 418IBA 01/2017
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2017
1	CytokinesIBA 01/2017
1	Calmodulin (Calcium-Dependent Activator Protein)IBA 09/2013
1	PiperazineIBA 08/2013
1	Volatile Oils (Essential Oils)IBA 12/2012
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 12/2012
1	PhytochemicalsIBA 12/2012
1	GuanineIBA 07/2012
1	U1 small nuclear RNAIBA 06/2012
1	Small Nuclear RNA (snRNA)IBA 06/2012

Therapy/Procedure

5	Therapeutics 12/2021 - 11/2014